Bacitracin Topical and Rapacuronium: Interaction Details
- Bacitracin Topical
- BaciguentBacitracin ZincFirst Aid Antibiotic +13 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Bacitracin Topical and Rapacuronium interaction:
Bacitracin Topical
- Baciguent
- Bacitracin Zinc
- First Aid Antibiotic
- Major Bacitracin
- CAREALL Bacitracin
- Single Antibiotic with bacitracin
- Medpride First Aid
- Live Better Bacitracin Zinc
- Premier Value Bacitracin Zinc
- ProCure Bacitracin Zinc
- procureFirst Aid Antibio First Aid Antibiotic
- Publix Bacitracin Zinc
- Rexall Antibiotic
- Sheffield Bacitracin Zinc
- signature care first aid antibiotic
- Single Antibiotic
Rapacuronium
We don't have a drug information page for Rapacuronium because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Rapacuronium? Ask a pharmacist, free →
What Happens When You Take Bacitracin Topical With Rapacuronium
What can happen when they are taken together (rated Major)
Enhanced or prolonged neuromuscular blockade
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
neuromuscular effects have been shown when polypeptide antibiotics are given together with nondepolarizing neuromuscular blockers. Because this class of antibiotics acts at both the pre-synaptic and post-synaptic regions of the myoneural junction, it works in concert with neuromuscular blockers.46523
The Bacitracin Topical and Rapacuronium Interaction, Explained
Rapacuronium is a strong muscle relaxant that was used during surgery to relax your muscles, including the ones you breathe with, so a breathing tube could be placed. Bacitracin is an antibiotic. Antibiotics in its family can also weaken the signal between nerves and muscles. Used together, the muscle-relaxing effect can be stronger or last longer than expected, which could make breathing on your own harder for a while after surgery.
Rapacuronium was taken off the US market years ago, so this mostly matters as a general caution. Bacitracin on the skin is absorbed only in small amounts, but it can be absorbed more when used on large wounds or during surgery. If you are having a procedure, tell your surgical team about any bacitracin you use. They are trained to watch your breathing and muscle strength closely and can support you safely.
Mechanism: PD interaction. Polypeptide antibiotics (bacitracin) reduce presynaptic acetylcholine release and/or exert postjunctional blockade, potentiating nondepolarizing NMBAs such as rapacuronium. No PK or component.
- Effect: Enhanced or prolonged neuromuscular blockade, possible postoperative requiring mechanical ventilation.
- Onset: Rapid. Evidence: Probable. Severity: Major.
- Context: Systemic from topical use is usually low but increases with large denuded areas, wound or cavity irrigation, or intraoperative application. Rapacuronium was withdrawn in the US (bronchospasm).
- Management: Avoid the combination. If unavoidable, monitor neuromuscular function (train-of-four) and ventilation closely, and be prepared for prolonged ventilatory support.
See the 6 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Bacitracin Topical and Rapacuronium Interact
The likely mechanism
Decreased presynaptic release of acetylcholine and/or postjunctional blocking activity by the antibiotic
How to Manage the Bacitracin Topical and Rapacuronium Interaction
The documented guidance is to avoid using these two together. If the combination cannot be avoided, your care team can manage it by:
- Watching you closely during and after the procedure for muscle weakness or slow recovery of breathing.
- Supporting your breathing with a machine if the muscle-relaxing effect lasts longer than expected.
What you can do: Before any surgery or procedure, tell your surgeon, anesthesia team, or pharmacist about any bacitracin you use, including ointments on wounds. Do not stop or change any medicine on your own. Ask your care team if you have questions.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Bacitracin Topical or Rapacuronium need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
5 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Two cases of prolonged respiratory depression due to interaction of pancuronium with colistin and streptomycin
Prolonged has been reported with the combined use of pancuronium and colistin. This exaggerated respiratory paralysis developed in a 55-year-old woman who had a laparotomy performed with thiopental, succinylcholine, and pancuronium.
Before surgery, she had been treated with gentamicin for nine days, followed by four days of colistin sulfate 1 million units given intramuscularly three times daily. About three hours after the final pancuronium dose, normal respiration was restored with 20 mL of 10% calcium gluconate.1
-
Report 2 · Study title
Colistimethate and curare: a case report
In a patient given 12 mg of tubocurarine over 1.5 hours, administration of neostigmine 3 mg together with atropine 1.5 mg did not reverse the neuromuscular blockade.2 A further dose of neostigmine 1.5 mg with atropine 1 mg was likewise ineffective.
Ventilation was maintained for three hours until spontaneous breathing appeared. After the operation, it was determined that the patient had been given a total of 11 grams of colistimethate on a schedule of 75 mg every eight hours.
-
Report 3 · Study title
Colistimethate as a cause of postoperative apnoea
A comparable report described a patient in whom reversal of curare was resistant to neostigmine after a surgical procedure involving 30 mg of tubocurarine. Before surgery, the patient had been given 17 doses of colistin methanesulfonate (dose not stated). Breathing resumed after calcium chloride 1 gram was given slowly.3
-
Report 4 · Study title
Recurrence of neuromuscular blockade after reversal of vecuronium in a patient receiving polymyxin/amikacin sternal irrigation
A single case has been reported in which neuromuscular blockade recurred after vecuronium use in a patient undergoing sternal irrigation with a solution containing polymyxin B 1 million units and amikacin 1 gram. Before the sternal irrigation was started, the blockade had been reversed with neostigmine and the patient was breathing spontaneously.
Nevertheless, within five minutes of starting the polymyxin/amikacin irrigation, controlled ventilation was again needed. The neuromuscular blockade persisted for about four hours, and the patient's recovery was uneventful.4
-
Report 5 · Study title
Prolongation of a pancuronium-induced neuromuscular blockade by polymyxin B
A 76-year-old man developed prolonged neuromuscular blockade after his surgical wound was irrigated with polymyxin B 250,000 units and bacitracin 50,000 units. He had received pancuronium 4.8 mg 35 minutes after anesthesia was induced. Although pyridostigmine 24.5 mg, neostigmine 1 mg, edrophonium 10 mg, and calcium chloride 1400 mg were administered, the neuromuscular blockade continued for 21 hours after the pancuronium dose.5
Bacitracin Topical and Rapacuronium: Common Questions
How serious is the Bacitracin Topical and Rapacuronium interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Bacitracin Topical and Rapacuronium interaction managed?
The documented guidance is to avoid using these two together. If the combination cannot be avoided, your care team can manage it by: Watching you closely during and after the procedure for muscle weakness or slow recovery of breathing. Supporting your breathing with a machine if the muscle-relaxing effect lasts longer than expected. What you can do: Before any surgery or procedure, tell your surge… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Bacitracin Topical and Rapacuronium Interaction
Ask in your own words about taking Bacitracin Topical and Rapacuronium together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (6)
- Giala MM & Paradelis AG: Two cases of prolonged respiratory depression due to interaction of pancuronium with colistin and streptomycin. J Antimicrob Chemother 1979; 5:234-235. PubMed
- Gebbie D: Colistimethate and curare: a case report. Anesth Analg 1971; 50:109-111. DOI
- Zauder HL, Barton N, Bennett EJ, et al: Colistimethate as a cause of postoperative apnoea. Can Anaesth Soc J 1966; 13:607-610. DOI
- Kronenfeld MA, Thomas SJ, & Turndorf H: Recurrence of neuromuscular blockade after reversal of vecuronium in a patient receiving polymyxin/amikacin sternal irrigation. Anesthesiology 1986; 65:93-94. PubMed
- Fogdall RP & Miller RD: Prolongation of a pancuronium-induced neuromuscular blockade by polymyxin B. Anesthesiology 1974; 40:84-87. DOI
- Lindesmith LA, Baines RD Jr, Bigelow DB, et al: Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med 1968; 68:318-327. PubMed
Other Serious Interactions of Bacitracin Topical and Rapacuronium
Also serious with Bacitracin Topical
Also serious with Rapacuronium
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Rapacuronium
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.